Gene ID | Gene Symbol | Description | Source |
---|---|---|---|
821 | CANX | calnexin | |
847 | CAT | catalase | |
929 | CD14 | CD14 molecule | |
960 | CD44 | CD44 molecule (IN blood group) | |
1012 | CDH13 | cadherin 13 | |
1048 | CEACAM5 | CEA cell adhesion molecule 5 | |
1087 | CEACAM7 | CEA cell adhesion molecule 7 | |
1103 | CHAT | choline O-acetyltransferase | |
1113 | CHGA | chromogranin A | |
1116 | CHI3L1 | chitinase 3 like 1 |
Gene ID | Gene Symbol | Description | Source |
---|---|---|---|
18654 | Pgf | placental growth factor | |
19013 | Ppara | peroxisome proliferator activated receptor alpha | |
19017 | Ppargc1a | peroxisome proliferative activated receptor, gamma, coactivator 1 alpha | |
19662 | Rbp4 | retinol binding protein 4, plasma | |
21898 | Tlr4 | toll-like receptor 4 | |
21926 | Tnf | tumor necrosis factor | |
56637 | Gsk3b | glycogen synthase kinase 3 beta |
Gene ID | Gene Symbol | Description | Source |
---|---|---|---|
31248 | sgg | shaggy | |
31579 | kdn | knockdown | |
31926 | Idgf4 | Imaginal disc growth factor 4 | |
32974 | Zw | Zwischenferment | |
34978 | Idgf1 | Imaginal disc growth factor 1 | |
34979 | Idgf2 | Imaginal disc growth factor 2 | |
34981 | Idgf3 | Imaginal disc growth factor 3 | |
36773 | Dg | Dystroglycan | |
36868 | Idgf6 | Imaginal disc growth factor 6 | |
37104 | Idgf5 | Imaginal disc growth factor 5 |
Gene ID | Gene Symbol | Description | Source |
---|---|---|---|
850361 | CIT2 | citrate (Si)-synthase CIT2 | |
851481 | MDH3 | malate dehydrogenase MDH3 | |
851977 | CTS2 | putative chitinase | |
853777 | MDH1 | malate dehydrogenase MDH1 | |
853994 | MDH2 | malate dehydrogenase MDH2 | |
855480 | ZWF1 | glucose-6-phosphate dehydrogenase | |
855732 | CIT1 | citrate (Si)-synthase CIT1 | |
856107 | CIT3 | citrate (Si)-synthase CIT3 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024